news
Supplement industry debates AI, money, and policy
The Council for Responsible Nutrition (CRN) just wrapped up its annual conference, CONVERGENCE 2026, where leaders discussed how artificial intelligence, private equity funding, and global regulations are shaping the future of supplements. They're trying to figure out what all these big forces mean for how new products get to market and what ends up in your cabinet. It's a big-picture look at how money and policy move product.
The Council for Responsible Nutrition (CRN) just wrapped up its annual conference, CONVERGENCE 2026, where leaders discussed how artificial intelligence, private equity funding, and global regulations are shaping the future of supplements. They're trying to figure out what all these big forces mean for how new products get to market and what ends up in your cabinet. It's a big-picture look at how money and policy move product.
The architecture take
I used to think these industry conferences were just for B2B back-patting. But this one's different: it's a peek behind the curtain at what will soon hit your body. When the big money (private equity) starts looking hard at supplements, and AI begins influencing product development, it means a lot more stuff is coming. Fast. Regulators like the FDA are already scrambling to keep up with the new ingredients and claims. The whole industry is trying to get ahead of what 'responsible' even means anymore, especially with AI creating new formulations or marketing claims faster than ever. It's not about what could be made, but what should be made, and how to prove it works before it lands in your hands. This is why policy is priority one for me. These discussions today shape your options tomorrow.